Full-Time

QC Analytical Methods Expert

Consultant

Posted on 8/27/2024

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Expert

Bridgewater Township, NJ, USA

Hybrid position requiring in-office presence.

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Required Skills
Google Cloud Platform
Requirements
  • Minimum 12 years of analytical or QC experience, CAR-T experience is highly desirable.
  • Cell/Gene Therapy experience preferred
  • Expertise in analytical methods pertinent to cell/gene therapy manufacturing
  • Ability to build strong partnerships and effectively integrate with external collaborators to drive projects/programs forward in a matrixed environment
  • Ability to work independently and successfully, prioritize and manage multiple tasks simultaneously, integrate cross-functional issues and balance competing priorities effectively
  • Ability to manage shifting priorities to meet critical deadlines in a fast paced and dynamic, growing environment
  • Expertise with methods and techniques for analysis of cell therapy products, such as Flow Cytometry, ELISA, qPCR, ddPCR, cell culture, cell count and viability measurement, and cytotoxicity assays.
  • Experience with analytical automation technology and vendor offerings specific to commercial analytical platforms, liquid handling & sample handling systems
  • Extensive knowledge in analytical best practices, industry standards and the latest technologies
  • Ability to think critically and demonstrated troubleshooting and problem-solving skills.
  • Results driven with strong analytical, problem solving and critical thinking skills.
  • Strong experience working in a cross-functional organization with multiple partners with competing priorities.
  • Ability to plan, multitask, prioritize and be an effective and influential decision maker focused on action and implementation.
Responsibilities
  • Subject matter expert of QC analytical methods in the areas of ELISA, qPCR, ddPCR assays, cell bioassays, Flow Cytometry and Rapid Sterility.
  • Evaluate analytical methods for feasibility, method improvement, remediation, and/or troubleshooting
  • Work with the software team on integration solutions for the QC process and data management, including MES, QMS, and LIMS
  • Work collaboratively with internal and external partners to identify and drive implementation of industry leading automation solutions
  • Coordinate and collaborate with AD/QC team in analytical method development and characterization of products that are currently in development
  • Identify, assess, and implement new technologies to improve product quality, success rate, reproducibility and/or reduce cost and time of the analytical processes
  • Drives plans for modification of existing analytical methods and ensuring that all methods are able to be integrated into an analytical automation platform
  • Identifies and drives plans for new analytical technologies that result in paradigm shift in throughput and capacity
  • Maintain current awareness of GMP/GLP/GCP/GDP, ICH, USP, and FDA guidelines, industry standards, and trends that apply to current and future Cell Therapy Development operations and products.

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
  • New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
  • Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

What critics are saying

  • Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
  • Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
  • Financial strain from new R&D facility could affect operational focus if advancements lag.

What makes Legend Biotech unique

  • Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
  • The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
  • Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

INACTIVE